Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study
NCT07664748
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Interventions
OTHER:
AVATAR-SC
DRUG:
Levosimendan
Sponsor
Niguarda Hospital